Article Details

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs ... - InvestorsObserver

Retrieved on: 2024-04-06 02:29:59

Tags for this article:

Click the tags to see associated articles and topics

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs ... - InvestorsObserver. View article details on hiswai:

Excerpt

23ME-01473, a novel anti-ULBP6/2/5 monoclonal antibody, reinvigorates anti-tumor NK cell function through NKG2D and FcγRIIIa activation; Session ...

Article found on: www.investorsobserver.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up